The expert panel for the Food and Drug Administration voted 19-1 that the drug’s modest benefits don’t outweigh its considerable risks, even with proposed measures to restrict who gets the medicine.
The guidelines stop short of two key recommendations from scientists advising the government. Those advisers said in July that everyone should limit their added sugar intake to less than 6% of calories and men should limit alcohol to one drink per day.
FDA Commissioner Stephen Hahn denied Saturday that the White House had threatened his job if the agency didn’t move quickly on the vaccine.
The U.S. gave the final go-ahead Friday to the nation’s first COVID-19 vaccine, marking what could be the beginning of the end of an outbreak that has killed nearly 300,000 Americans.
The announcement by the Food and Drug Administration represents an important step in U.S. efforts to expand testing options for COVID-19. However, the test will require a prescription, likely limiting its initial use.
FDA Commissioner Stephen Hahn has pledged that career scientists, not politicians, will decide whether any coronavirus vaccine meets clearly stated standards that it works and is safe.
The FDA also advises Americans to be wary of products that claim to be “FDA-approved,” as none exist, or say they provide protection for “up to 24 hours.”
President Donald Trump said Wednesday his administration will propose banning thousands of flavors used in e-cigarettes to combat a recent surge in underage vaping.
CVS Health, which started carrying CBD skin products in some states this year, plans to remove Curaleaf products from its shelves following the FDA’s warning.
In recent months, the drugmaker has won federal approval to sell a drug called Emgality for two conditions: migraine pain and cluster headaches.
The move comes as companies are turning to newer genetic engineering techniques that make it easier to tinker with the traits of plants and animals.
By clarifying terms such as “Sell by” and “Use by,” U.S. regulators are trying to prevent people from prematurely tossing products and to reduce the mountains of food that goes to waste each year.
Paul Elmer, who founded Pharmakon 16 years ago and shut it down three years ago, faces charges of adulterating compounded drugs, conspiracy and obstructing a U.S. FDA investigation.
Scott Gottlieb bucked expectations by pushing the agency to expand its authorities in several key ways, including an unprecedented effort to make cigarettes less addictive by requiring lower nicotine levels .
Congress legalized the production and sale of industrial hemp and hemp derivatives, including CBD. But FDA Commissioner Scott Gottlieb has restated his agency’s stance that CBD is a drug ingredient and therefore illegal to add to food or health products without his agency’s approval.
FDA Commissioner Scott Gottlieb said the FDA wanted to issue a warning about a new E. coli outbreak before people gathered for Thanksgiving meals, where the potential for exposure could increase.
The move represents a major step to further push down U.S. smoking rates, which have been falling for decades.
New limitations will be placed on e-cigarettes, according to a senior FDA official, restricting sales of many popular fruit flavors amid what the health agency has called an epidemic of youth use.
The experimental drug eased arthritis pain in hard-to-treat patients without major safety concerns, a key step in creating a new class of medications that may one day offer an alternative to narcotics.
Eli Lilly and Co. received clearance Thursday from U.S. regulators for a new migraine drug that will be the third in a promising class of therapies for patients who suffer from the recurrent, painful headaches.
